The U.S. durable medical equipment market size was valued at USD 49.9 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 6.0% from 2020 to 2027. An increase in the prevalence of chronic disease, rapid technological advancements, and a rising aging population are the leading factors propelling the overall demand for durable medical equipment (DME) in the country. Rising product approvals are projected to further fuel the product demand. Durable medical equipment is the medical device used for improving the quality of the life of the patients. Some of the common DME include wheelchairs, blood sugar monitors, and nebulizers. The expansion of competitive bidding is expected to control the reimbursement rate of the products, which is likely to drive retail sales of several products in the forthcoming years.
The rising incidence of chronic diseases such as cancer, multiple sclerosis, and rheumatoid arthritis, is anticipated to drive the demand for DME. As per the National Cancer Institute Report 2018, approximately 1.7 million people in the U.S. were diagnosed with cancer. Moreover, around a 70.0% rise is expected in new cases of cancer over the next couple of years. Such a significant rise in the disease occurrence is anticipated to drive the product demand. Neurological disorders, such as epilepsy and Alzheimer’s and Parkinson’s diseases are also expected to witness a surge in occurrence over the forecast period. As per a survey carried out by the American Neurological Association in 2017, around 5.3 million people in the U.S. were suffering from Alzheimer’s.
The increasing geriatric population is one of the important factors driving the growth of the U.S. durable medical equipment market. As per a survey carried out by the Population Reference Bureau in 2019, over 52 million people in the U.S. were aged 65 years and above. This number is anticipated to increase to 95 million by 2050. The geriatric population presents a greater exposure to chronic conditions, such as cancer, diabetes, and other lifestyle chronic disorders. Hence, the demand for DME is expected to increase in the near future.
On the basis of product type, the U.S. market for durable medical equipment is segmented into personal mobility devices, bathroom safety devices and medical furniture, and monitoring and therapeutic devices. Monitoring and therapeutic devices accounted for the largest market share in 2019 due to their ease of use, convenience, and patient preference for the equipment.
Based on bathroom safety devices and medical furniture, the market is sub-segmented into commodes and toilets and mattresses and bedding devices. The monitoring and therapeutic devices are sub-segmented into blood sugar monitors, Continuous Passive Motion (CPM), infusion pumps, nebulizers, oxygen equipment, Continuous Positive Airway Pressure (CPAP), suction pumps, traction equipment, and others. Monitoring and therapeutic devices are held around 90.0% market share in 2019. This equipment is most widely used for long-term care in the case of cancer, neurological disorders, and cardiovascular and other such chronic diseases.
The others segment is expected to account for the major market share during the forecast period due to the increasing demand for wireless monitoring devices and the prevalence of lifestyle-related diseases that require routine examination of vital statistics. Whereas personal mobility devices are projected to register the fastest CAGR of 6.3% over the forecast period. Technological advancement in durable medical equipment is likely to aid segment growth. These devices include a wheelchair, scooters, walkers and rollators, canes and crutches, and door openers. The wheelchair is expected to dominate this segment due to its increasing demand and high usage rate. It is estimated that around 3.3 million patients in the U.S. use wheelchairs for day-to-day mobility needs.
Advancements in medical devices technologies, advanced healthcare infrastructure, and high demand for quality products are some of the factors anticipated to boost the demand for DME equipment in the U.S. According to a survey carried out by the National Center for Biotechnology Information (NCBI) in 2018, around 133 million people in the country suffer from at least one chronic disease. Hence, the DME market is expected to witness significant growth during the forecast period.
The U.S. DME market is highly competitive. Some of the players operating in the market include Invacare Corporation; Sunrise Medical; ArjoHuntleigh; Hill-Rom; Stryker; Medline Industries, Inc.; Medical Device Depot, Inc.; GF Health Products Inc.; Carex Health Brands; Baxter International, Inc.; Becton, Dickinson and Company; and Joerns Healthcare LLC.
Key parameters affecting the competitive nature are the rapid adoption of advanced devices for improved healthcare. Also, the major players often undertake mergers and acquisitions along with new product launches in order to retain share and diversify the product portfolio. In February 2017, Hill-Rom acquired Mortara Instrument, Inc., a Wisconsin-based medical device manufacturer, to increase its product portfolio and revenue growth.
Report Attribute |
Details |
Market size value & volume in 2020 |
USD 52,905.4 million |
Revenue & volume forecast in 2027 |
USD 79,562.4 million |
Growth Rate |
CAGR of 6.0% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Revenue in USD million, volume in thousand, and CAGR from 2020 to 2027 |
Report coverage |
Revenue & volume forecast, company share, competitive landscape, growth factors and trends |
Segments covered |
Product |
Country scope |
U.S |
Key companies profiled |
Invacare Corporation; Sunrise Medical; ArjoHuntleigh; Hill-Rom; Stryker; Medline Industries, Inc.; Medical Device Depot, Inc.; GF Health Products Inc.; Carex Health Brands; Baxter International, Inc.; Becton, Dickinson and Company; Joerns Healthcare LLC |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail of customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the U.S. durable medical equipment market report on the basis of product:
Product Type Outlook (Volume, Thousand Units; Revenue, USD Million, 2016 - 2027)
Personal Mobility Devices
Wheelchairs
Scooters
Walker and Rollators
Canes and Crutches
Door Openers
Other Devices
Bathroom Safety Devices and Medical Furniture
Commodes and Toilets
Mattress & Bedding Devices
Monitoring and Therapeutic Devices
Blood Sugar Monitors
Continuous Passive Motion (CPM)
Infusion Pumps
Nebulizers
Oxygen equipment
Continuous Positive Airway Pressure (CPAP)
Suction pumps
Traction Equipment
Others
Insulin pumps
Ostomy bags and accessories
Wound care products
Cardiology Devices
Vital Signs Monitor
Respiratory supplies
Urinary supplies
Diabetic supplies
Incontinence products
Orthopedic braces and support
Muscle stimulators
Others
b. The U.S. durable medical equipment market size was established at USD 49,910.7 million in 2019 and is expected to reach USD 52,905.4 million in 2020.
b. The U.S. durable medical equipment market is expected to grow at a compound annual growth rate of 6.0% from 2020 to 2027 to reach USD 79,562.4 million by 2027.
b. The monitoring and therapeutic devices segment dominated the U.S. durable medical equipment market with a share of 89% in 2019. This is attributable to their ease of use, convenience, and patient preference for the equipment.
b. Some key players operating in the U.S. durable medical equipment market include Invacare Corporation; Sunrise Medical; ArjoHuntleigh; Hill-Rom; Stryker; Medline Industries, Inc.; Medical Device Depot, Inc.; GF Health Products Inc.; Carex Health Brands; Baxter International, Inc.; Becton, Dickinson and Company; and Joerns Healthcare LLC.
b. Key factors that are driving the market growth include an increase in the prevalence of chronic disease, rapid technological advancements, and rising aging population.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.